FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2919852783> ?p ?o ?g. }

• W2919852783 endingPage "1367" @default.
• W2919852783 startingPage "1359" @default.
• W2919852783 abstract "Abstract The purpose of this retrospective study was to compare the efficacy and toxicity of high‐dose methotrexate plus temozolomide (MT regimen) and rituximab plus MT (RMT regimen) in patients with untreated primary central nervous system lymphoma (PCNSL). A total of 62 patients with untreated PCNSL were enrolled between January 2005 and December 2015, with the median age of 53.5 years (range 29‐77).In this study, 32 patients received RMT as induction therapy, and 30 received MT. Objective responses were noted in 93.7% of the patients in the RMT group and in 69.0% of the patients in the MT group ( P = 0.018), while complete responses were noted in 53.2% of the patients in the RMT group and 27.6% of the patients in the MT group ( P < 0.001). The 2‐ and 5‐year PFS rates were 81.3% and 53.3%, respectively, for the RMT group and 46.5% and 29.1%, respectively, for the MT group ( P = 0.019). The 2‐ and 5‐year overall survival (OS) rates were 82.3% and 82.3%, respectively, for the RMT group and 65.7% and 50.0%, respectively, for the MT group ( P = 0.015). Multivariate analyses showed that therapeutic regimen (RMT vs MT) was an independent prognostic factor for PFS and OS. Our encouraging results suggest that the RMT regimen may be a feasible and safe therapeutic approach for first‐line treatment of PCNSL." @default.
• W2919852783 created "2019-03-11" @default.
• W2919852783 creator A5005765923 @default.
• W2919852783 creator A5014307249 @default.
• W2919852783 creator A5015287299 @default.
• W2919852783 creator A5018198768 @default.
• W2919852783 creator A5022499603 @default.
• W2919852783 creator A5028322534 @default.
• W2919852783 creator A5029528457 @default.
• W2919852783 creator A5031344912 @default.
• W2919852783 creator A5038871279 @default.
• W2919852783 creator A5042092772 @default.
• W2919852783 creator A5055125144 @default.
• W2919852783 creator A5061873068 @default.
• W2919852783 creator A5083135287 @default.
• W2919852783 creator A5088465882 @default.
• W2919852783 date "2019-03-01" @default.
• W2919852783 modified "2023-10-16" @default.
• W2919852783 title "High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China" @default.
• W2919852783 cites W1985027375 @default.
• W2919852783 cites W1994004225 @default.
• W2919852783 cites W1995358351 @default.
• W2919852783 cites W2018071905 @default.
• W2919852783 cites W2069078363 @default.
• W2919852783 cites W2092788728 @default.
• W2919852783 cites W2100485814 @default.
• W2919852783 cites W2111322227 @default.
• W2919852783 cites W2111412973 @default.
• W2919852783 cites W2115623838 @default.
• W2919852783 cites W2123689120 @default.
• W2919852783 cites W2124559325 @default.
• W2919852783 cites W2126027092 @default.
• W2919852783 cites W2135838006 @default.
• W2919852783 cites W2146598534 @default.
• W2919852783 cites W2148613344 @default.
• W2919852783 cites W2151890155 @default.
• W2919852783 cites W2154647431 @default.
• W2919852783 cites W2157338776 @default.
• W2919852783 cites W2303343204 @default.
• W2919852783 cites W2313246394 @default.
• W2919852783 cites W2314481096 @default.
• W2919852783 cites W2318630604 @default.
• W2919852783 cites W2337800630 @default.
• W2919852783 cites W2351516059 @default.
• W2919852783 cites W2556517183 @default.
• W2919852783 cites W2605495258 @default.
• W2919852783 cites W2619812087 @default.
• W2919852783 cites W2754305636 @default.
• W2919852783 cites W2767345813 @default.
• W2919852783 cites W2778583831 @default.
• W2919852783 cites W2789539827 @default.
• W2919852783 cites W4251009938 @default.
• W2919852783 cites W66387040 @default.
• W2919852783 doi "https://doi.org/10.1002/cam4.1906" @default.
• W2919852783 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6488123" @default.
• W2919852783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30821418" @default.
• W2919852783 hasPublicationYear "2019" @default.
• W2919852783 type Work @default.
• W2919852783 sameAs 2919852783 @default.
• W2919852783 citedByCount "8" @default.
• W2919852783 countsByYear W29198527832020 @default.
• W2919852783 countsByYear W29198527832021 @default.
• W2919852783 countsByYear W29198527832022 @default.
• W2919852783 countsByYear W29198527832023 @default.
• W2919852783 crossrefType "journal-article" @default.
• W2919852783 hasAuthorship W2919852783A5005765923 @default.
• W2919852783 hasAuthorship W2919852783A5014307249 @default.
• W2919852783 hasAuthorship W2919852783A5015287299 @default.
• W2919852783 hasAuthorship W2919852783A5018198768 @default.
• W2919852783 hasAuthorship W2919852783A5022499603 @default.
• W2919852783 hasAuthorship W2919852783A5028322534 @default.
• W2919852783 hasAuthorship W2919852783A5029528457 @default.
• W2919852783 hasAuthorship W2919852783A5031344912 @default.
• W2919852783 hasAuthorship W2919852783A5038871279 @default.
• W2919852783 hasAuthorship W2919852783A5042092772 @default.
• W2919852783 hasAuthorship W2919852783A5055125144 @default.
• W2919852783 hasAuthorship W2919852783A5061873068 @default.
• W2919852783 hasAuthorship W2919852783A5083135287 @default.
• W2919852783 hasAuthorship W2919852783A5088465882 @default.
• W2919852783 hasBestOaLocation W29198527831 @default.
• W2919852783 hasConcept C126322002 @default.
• W2919852783 hasConcept C141071460 @default.
• W2919852783 hasConcept C167135981 @default.
• W2919852783 hasConcept C2776694085 @default.
• W2919852783 hasConcept C2777389519 @default.
• W2919852783 hasConcept C2779338263 @default.
• W2919852783 hasConcept C2780653079 @default.
• W2919852783 hasConcept C2781059491 @default.
• W2919852783 hasConcept C2781173314 @default.
• W2919852783 hasConcept C2781413609 @default.
• W2919852783 hasConcept C71924100 @default.
• W2919852783 hasConcept C90924648 @default.
• W2919852783 hasConceptScore W2919852783C126322002 @default.
• W2919852783 hasConceptScore W2919852783C141071460 @default.
• W2919852783 hasConceptScore W2919852783C167135981 @default.
• W2919852783 hasConceptScore W2919852783C2776694085 @default.
• W2919852783 hasConceptScore W2919852783C2777389519 @default.
• W2919852783 hasConceptScore W2919852783C2779338263 @default.

• next